tiprankstipranks
Trending News
More News >
Vistagen Therapeutics Inc. (VTGN)
:VTGN
US Market

VistaGen Therapeutics (VTGN) Income Statement

Compare
834 Followers

VistaGen Therapeutics Income Statement

Last quarter (Q4 2025), VistaGen Therapeutics's total revenue was $-15.00K, a decrease of -107.60% from the same quarter last year. In Q4, VistaGen Therapeutics's net income was $-13.63M. See VistaGen Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 486.00K$ 1.06M$ -227.00K$ 1.11M$ 1.09M
Gross Profit
$ 486.00K$ 1.06M$ -227.00K$ 1.11M$ 1.09M
Operating Expenses
$ 56.46M$ 34.09M$ 59.04M$ 48.89M$ 19.02M
Depreciation and Amortization
$ 635.00K$ 568.00K$ 532.00K$ 711.10K$ 477.60K
EBITDA
$ -55.34M$ -32.45M$ -58.74M$ -47.05M$ -17.44M
Operating Income
$ -55.97M$ -33.02M$ -59.27M$ -47.78M$ -17.93M
Other Income/Expenses
$ 4.56M$ 3.66M$ 26.00K$ 19.90K$ 2.20K
Pretax Income
$ -51.41M$ -29.36M$ -59.24M$ -47.76M$ -17.93M
Net Income
$ -51.42M$ -29.36M$ -59.25M$ -47.76M$ -17.93M
Per Share Metrics
Basic EPS
$ 0.00$ -1.52$ -8.51$ -7.24$ -6.25
Diluted EPS
$ 0.00$ -1.52$ -8.51$ -7.24$ -6.25
Weighted Average Shares Outstanding
0.00 19.35M 6.96M 6.60M 2.87M
Weighted Average Shares Outstanding (Diluted)
0.00 19.35M 6.96M 6.60M 2.87M
Currency in USD

VistaGen Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis